Cellulitis and mouth abscess
Conditions
Interventions
This is a randomized, controlled, two-arm, open-label clinical trial that will include 60 patients with deep odontogenic infection, randomly distributed into two groups, 30 patients undergoing vacuum
Sponsors
Universidade Federal dos Vales do Jequitinhonha e Mucuri
Hospital Metropolitano Odilon Behrens
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients over 18 years of age; both sexes; hospitalized due to severe odontogenic infection and with indication of extraoral drainage in primary facial spaces: buccal, submandibular and/or submental; Such patients must be classified by the American Anesthesiology Association (ASA), as ASA I - good general health or ASA II - compensated underlying disease
Exclusion criteria
Exclusion criteria: Patients with a history of hypersensitivity to any of the components of the medications used; patients classified as American Association of Anesthesiology - ASA III or ASA IV; patients with tuberculosis, collagen vascular diseases, multiple sclerosis, Human Immunodeficiency Virus (HIV) infection, and other autoimmune diseases; pregnant and breastfeeding women; patients with cognitive disorders that make it impossible to understand and execute commands; withdrawal of consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a reduction in hospital stay time | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to find an improvement in the reduction of trismus;A reduction in the CRP test and the number of leukocytes is expected. | — |
Countries
Brazil
Contacts
Public ContactRafael Magesty
Universidade Federal dos Vales do Jequitinhonha e Mucuri
Outcome results
None listed